These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 2290848)
1. Clinical testing of compounds modifying acute and chronic neurodegeneration in the CNS. Etienne P; Hakim A Prog Clin Biol Res; 1990; 361():387-407. PubMed ID: 2290848 [No Abstract] [Full Text] [Related]
2. [A real advance in therapy for clinical practice]. Möller HJ Fortschr Med Suppl; 1990; 103():17-9. PubMed ID: 2279725 [No Abstract] [Full Text] [Related]
3. The use of nimodipine (Nimotop-Bayer) in patients with chronic ischemic cerebral vasculopathies. Twenty-eight case reports. Politi GC; Romanini BM; Belloli PA; Rossi A; Bellaviti N; Pucci C; Ferro C Panminerva Med; 1990; 32(2):85-7. PubMed ID: 2250979 [TBL] [Abstract][Full Text] [Related]
4. [Nimodipine in ischemic cerebropathy]. Di Lascio G; Salvini S Clin Ter; 1993 Feb; 142(2):123-6. PubMed ID: 8472525 [TBL] [Abstract][Full Text] [Related]
5. [The use of nimodipine in comatose patients with different types of cerebrovascular pathology]. Alia G; Mattaliano A Clin Ter; 1993 Oct; 143(4):295-301. PubMed ID: 8258263 [TBL] [Abstract][Full Text] [Related]
7. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders. Di Mascio R; Marchioli R; Tognoni G Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186 [TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on the use of gangliosides in acute cerebrovascular diseases]. Lipparini R; Broccoli PL; Albini U; Pangia A Minerva Med; 1975 Oct; 66(72):3774-84. PubMed ID: 1103014 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of vascular diseases of the nervous system with Viquidil hydrochloride]. Boudouresques J; Gosset A Mars Med; 1972; 109(6):453-6. PubMed ID: 4563604 [No Abstract] [Full Text] [Related]
10. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine]. Cosmi F; Caresia L; Panebianco G Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528 [No Abstract] [Full Text] [Related]
11. Stroke, Alzheimer's patients may benefit from AIDS dementia drug. Dent Today; 1997 Feb; 16(2):29. PubMed ID: 9560599 [No Abstract] [Full Text] [Related]
12. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency]. De Pergola E; Di Lorenzo L; De Pergola G G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986 [No Abstract] [Full Text] [Related]
13. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025 [TBL] [Abstract][Full Text] [Related]
14. Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders. Albizzati MG; Bassi S; Sbacchi M; Frattola L Br J Clin Pract Suppl; 1984; 34():69-73. PubMed ID: 6430327 [No Abstract] [Full Text] [Related]
15. Use of calcium channel blockers in acute ischemic cerebrovascular disease. Dalal PM; Dalal KP J Assoc Physicians India; 1995 Jun; 43(6):394-7. PubMed ID: 8906943 [TBL] [Abstract][Full Text] [Related]
16. Does a good model exist for controlled clinical trials in cerebrovascular disease? De Reuck J Acta Neurol Belg; 1988; 88(1):58-60. PubMed ID: 3389072 [No Abstract] [Full Text] [Related]
17. [Gerontologic evaluation of the effect of bencyclane]. Lengyel E; Bálint T; Drietomszky J; Duray A; Fráter R; Gáll J; Wagner E Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1445+. PubMed ID: 4921871 [No Abstract] [Full Text] [Related]
18. [Clinical and electroencephalographic studies of the effect of nicergoline in cerebrovascular diseases]. Montanini R; Gasco P; Manfredini G Acta Neurol (Napoli); 1973; 28(2):133-49. PubMed ID: 4575428 [No Abstract] [Full Text] [Related]